Skip to content

Comparison of Naproxen and Paracetamol for pain relief during endometrial biopsy in non-pregnant women with abnormal uterine bleeding; A randomized controlled trial

Comparison of Naproxen and Paracetamol for pain relief during endometrial biopsy in non-pregnant women with abnormal uterine bleeding; A randomized controlled trial

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230222001
Enrollment
198
Registered
2023-02-22
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain from endometrial biopsy by using manual vacuum aspiration abnormal uterine bleeding manual vacuum aspiration pain endometrial biopsy

Interventions

NAPROXEN tablet 250 mg oral route preparation in capsule,Paracetamol tablet 500 mg oral route preparation in capsule,Placebo, Corn starch filled capsule
Naproxen,Paracetamol,Placebo

Sponsors

Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.) A non-pregnant woman who has abnormal bleeding from uterus, age between 30 - 70 years old, with one of following criteria a. Age >/= 45 years b. Age < 45 years with unopposed estrogen exposure or chronic anovulation c. Persistent abnormal uterine bleeding 3.) Not an anti-platelet or anti-coagulant agents user 4.) Adequate communication with Thai 5.) Consented to join the trial

Exclusion criteria

Exclusion criteria: 1. A woman who has had Paracetamol or NSAIDs agents within 24 hours before 2. A woman who has a history of allergy to NSAIDs or Paracetamol 3. A woman who has any contraindications in Naproxen using, such as peptic ulcer, asthma, bleeding disorder, and impaired renal or hepatic function; GFR < 30mL/min/1.73m2 4. A woman who has any contraindications in Paracetamol using, such as impaired liver function; AST >100 U/L or ALT > 100U/L), and alcoholism. 5. A woman who cannot understand the Visual Analogue Scale (VAS) 6. Participants who need to withdraw from the trial.

Design outcomes

Primary

MeasureTime frame
Pain level immediately after the procedure finished and 10 minutes after the procedure Visual Analogue Scale

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactKritakarn Telapol

Panyananthaphikkhu Chonprathan Medical Center

kritakarn@g.swu.ac.th0967427547

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026